Home / Pharma news / Indian drug companies bet on global M&As in growth pursuit

Indian drug companies bet on global M&As in growth pursuit

Indian drug companies will continue scouting for acquiring overseas assets over the next two years to enhance their presence in developed and emerging markets, according to .

“Indian pharmaceutical companies will continue to seek growth through the acquisition of overseas assets or companies in the next 18-24 months, with the aim of deepening their geographic and product diversity, and increasing their presence in developed and emerging markets,” Moody’s Investors Service said in a  ..

Check Also

Diabetes-Silent Killer

The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion ...

%d bloggers like this: